Prenetics Global Limited
(PRE)
undefined
undefined%
At close: undefined
6.00
6.89%
After-hours Dec 13, 2024, 05:01 PM EST
Company Description
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company.
Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test.
The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem.
Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Prenetics Global Limited
Country | HK |
IPO Date | Jul 16, 2021 |
Industry | Medical - Diagnostics & Research |
Sector | Healthcare |
Employees | 320 |
CEO | Sheng Wu Yeung |
Contact Details
Address: Unit 701-706, K11 Atelier King’s Road Quarry Bay, HK | |
Website | https://www.prenetics.com |
Stock Details
Ticker Symbol | PRE |
Exchange | NASDAQ |
Fiscal Year | n/a |
Reporting Currency | USD |
CIK Code | 0001876431 |
CUSIP Number | G72245106 |
ISIN Number | KYG722451229 |
Employer ID | 00-0000000 |
SIC Code | 3826 |
Key Executives
Name | Position |
---|---|
Joel Neoh | Chief Consumer Officer & Chief Executive Officer for CircleDNA |
Samantha Kwok | Chief of Staff to Group Chief Executive Officer & Vice President of People & Operations |
Sheng Wu Yeung | Co-Founder, Chairperson & Chief Executive Officer |
Walt Ling | Chief Executive Officer of ACT Genomics |
Dr. Yung Ho Wong DPHIL | Chief Technology Officer |
Hoi Chun Lo | Chief Financial Officer |
Dr. Chi Hung Tzang Ph.D. | Co-Founder & Chief Scientific Officer |
Dr. Senthil Sundaram M.D. | Chief Clinical Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 13, 2024 | 6-K | Filing |
Nov 27, 2024 | 6-K | Filing |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 07, 2024 | SCHEDULE 13G/A | [Amend] Filing |
Oct 15, 2024 | 6-K | Filing |
Oct 07, 2024 | 6-K | Filing |
Sep 27, 2024 | 6-K | Filing |
Sep 16, 2024 | 6-K | Filing |
Aug 19, 2024 | 6-K | Filing |
Jul 11, 2024 | 6-K/A | [Amend] Filing |